Related Experiment Video
Updated: Feb 5, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Loss of ROR2 Tyrosine Kinase Receptor Is Associated With Endothelial Dysfunction in PAH via Inappropriate Integrin β1
Ankita Mitra1, Stuti Agarwal1, Ananya Chakraborty1
1Division of Pulmonary and Critical Care (A.M., S.A., A.C., A.R., A.B., A.P., N.A., P.C., A.J., J.A.M.M., E.S.G., V.A.d.J.P.), Stanford University, Palo Alto, CA.
Loss of receptor tyrosine kinase-like orphan receptor 2 (ROR2) worsens pulmonary arterial hypertension by impairing endothelial barrier integrity. Restoring ROR2 function may offer a new therapeutic strategy for PAH.
Area of Science:
- Cardiovascular Research
- Pulmonary Medicine
- Cell Biology
Background:
- Endothelial dysfunction is a hallmark of pulmonary arterial hypertension (PAH).
- Previous research linked decreased Wnt7a transcript levels to reduced angiogenesis in PAH.
- Wnt7a expression correlates with tip formation via receptor tyrosine kinase-like orphan receptor 2 (ROR2).
Purpose of the Study:
- To investigate the role of ROR2 activation in pulmonary microvascular endothelial cells (PMVECs).
- To determine if ROR2 promotes angiogenesis and endothelial barrier establishment.
- To test the hypothesis that ROR2 loss contributes to PAH.
Main Methods:
- Studied endothelial-specific ROR2 knockout (ROR2 ECKO) and wild-type mice under normoxia and hypoxia.
- Utilized echocardiography, hemodynamics, and lung morphometry.
- Performed functional and molecular studies on PMVECs using ROR2 siRNA/constructs and transcriptomic analyses.
Main Results:
- ROR2 ECKO mice showed exacerbated pulmonary hypertension and vascular remodeling.
- Single-cell RNA-sequencing revealed dysregulated barrier formation and angiogenesis in ROR2 ECKO lungs.
- ROR2 deficiency in PAH PMVECs increased adhesion and permeability, with ROR2 interacting with integrin β1 (ITGB1) in focal adhesions.
Conclusions:
- ROR2 is crucial for pulmonary angiogenesis by maintaining endothelial barrier integrity and facilitating integrin recycling.
- ROR2-ITGB1 crosstalk, mediated by Rab12, is a key pathway.
- ROR2 restoration presents a potential therapeutic avenue for PAH.
Related Concept Videos
Receptor Tyrosine Kinases
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...

